Black, Hispanic Alzheimer’s patients excluded from new drug testing
[ad_1] New promising treatments for Alzheimerโs disease may not be as beneficial for black and Hispanic sufferers. Leqembi and donanemab, an experimental antibody developed by Eli Lilly, are the first […]
Black, Hispanic Alzheimer’s patients excluded from new drug testing Read More ยป























